Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 515

1.

The effects of electroconvulsive therapy on GABAergic function in major depressive patients.

Esel E, Kose K, Hacimusalar Y, Ozsoy S, Kula M, Candan Z, Turan T.

J ECT. 2008 Sep;24(3):224-8. doi: 10.1097/YCT.0b013e31815cbaa1.

PMID:
18562944
[PubMed - indexed for MEDLINE]
2.

[Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder].

Ozsoy S, Eşel E, Hacimusalar Y, Candan Z, Kula M, Turan T.

Turk Psikiyatri Derg. 2008 Winter;19(4):341-8. Turkish.

PMID:
19110975
[PubMed - indexed for MEDLINE]
Free Article
3.

Effects of electroconvulsive therapy on plasma GABA.

Devanand DP, Shapira B, Petty F, Kramer G, Fitzsimons L, Lerer B, Sackeim HA.

Convuls Ther. 1995 Mar;11(1):3-13.

PMID:
7796065
[PubMed - indexed for MEDLINE]
4.

Changes in plasma amino acids after electroconvulsive therapy of depressed patients.

Palmio J, Huuhka M, Saransaari P, Oja SS, Peltola J, Leinonen E, Suhonen J, Keränen T.

Psychiatry Res. 2005 Dec 15;137(3):183-90. Epub 2005 Nov 17.

PMID:
16297983
[PubMed - indexed for MEDLINE]
5.

Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course.

Markianos M, Hatzimanolis J, Lykouras L.

Eur Arch Psychiatry Clin Neurosci. 2002 Aug;252(4):172-6.

PMID:
12242578
[PubMed - indexed for MEDLINE]
6.

A preliminary study of the effects of electroconvulsive therapy on regional brain glucose metabolism in patients with major depression.

Yatham LN, Clark CC, Zis AP.

J ECT. 2000 Jun;16(2):171-6.

PMID:
10868326
[PubMed - indexed for MEDLINE]
7.

Growth hormone response to baclofen in patients with seasonal affective disorder: effects of light therapy.

Shiah IS, Robertson HA, Lam RW, Yatham LN, Tam EM, Zis AP.

Psychoneuroendocrinology. 1999 Feb;24(2):143-53. Erratum in: Psychoneuroendocrinology 2000 Apr;25(3):315.

PMID:
10101723
[PubMed - indexed for MEDLINE]
8.

Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients.

Maayan R, Yagorowski Y, Grupper D, Weiss M, Shtaif B, Kaoud MA, Weizman A.

Biol Psychiatry. 2000 Oct 1;48(7):693-701.

PMID:
11032981
[PubMed - indexed for MEDLINE]
9.

Growth hormone response to the GABAB agonist baclofen in major depressive disorder.

Davis LL, Trivedi M, Choate A, Kramer GL, Petty F.

Psychoneuroendocrinology. 1997 Apr;22(3):129-40.

PMID:
9203224
[PubMed - indexed for MEDLINE]
10.

Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.

Piccinni A, Del Debbio A, Medda P, Bianchi C, Roncaglia I, Veltri A, Zanello S, Massimetti E, Origlia N, Domenici L, Marazziti D, Dell'Osso L.

Eur Neuropsychopharmacol. 2009 May;19(5):349-55. doi: 10.1016/j.euroneuro.2009.01.002. Epub 2009 Feb 15.

PMID:
19223156
[PubMed - indexed for MEDLINE]
11.

Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.

Marano CM, Phatak P, Vemulapalli UR, Sasan A, Nalbandyan MR, Ramanujam S, Soekadar S, Demosthenous M, Regenold WT.

J Clin Psychiatry. 2007 Apr;68(4):512-7.

PMID:
17474805
[PubMed - indexed for MEDLINE]
12.

Increased cortical GABA concentrations in depressed patients receiving ECT.

Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, Berman RM, Krystal JH.

Am J Psychiatry. 2003 Mar;160(3):577-9.

PMID:
12611844
[PubMed - indexed for MEDLINE]
13.

SPECT and neuropsychological performance in severe depression treated with ECT.

Mervaala E, Könönen M, Föhr J, Husso-Saastamoinen M, Valkonen-Korhonen M, Kuikka JT, Viinamäki H, Tammi AK, Tiihonen J, Partanen J, Lehtonen J.

J Affect Disord. 2001 Sep;66(1):47-58.

PMID:
11532532
[PubMed - indexed for MEDLINE]
14.

Effects of electroconvulsive therapy on hypothalamic-pituitary-thyroid axis activity in depressed patients.

Esel E, Turan T, Kula M, Reyhancan M, Gonul A, Basturk M, Sofuoglu S.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct;26(6):1171-5.

PMID:
12452542
[PubMed - indexed for MEDLINE]
15.

Cortical gamma-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy.

Sanacora G, Fenton LR, Fasula MK, Rothman DL, Levin Y, Krystal JH, Mason GF.

Biol Psychiatry. 2006 Feb 1;59(3):284-6. Epub 2005 Sep 1.

PMID:
16139814
[PubMed - indexed for MEDLINE]
16.

Growth hormone and somatomedin serum levels in patients with major depressive illness undergoing electroconvulsive therapy.

Apéria B, Thorén M, Undén F, Wetterberg L.

Acta Psychiatr Scand. 1986 Jun;73(6):681-7.

PMID:
3751671
[PubMed - indexed for MEDLINE]
17.

Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.

Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, Abate M, Segala M, Giacopuzzi M, Riva MA, Marchina E, Pasqualetti P, Perez J, Gennarelli M.

Eur Neuropsychopharmacol. 2006 Dec;16(8):620-4. Epub 2006 Jun 6.

PMID:
16757154
[PubMed - indexed for MEDLINE]
18.
19.

Effects of electroconvulsive therapy on the thyrotropin-releasing hormone test in patients with depression.

Esel E, Kilic C, Kula M, Basturk M, Ozsoy S, Turan T, Keles S, Sofuoglu S.

J ECT. 2004 Dec;20(4):248-53.

PMID:
15591859
[PubMed - indexed for MEDLINE]
20.

Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study.

Grunhaus L, Dannon PN, Schreiber S, Dolberg OH, Amiaz R, Ziv R, Lefkifker E.

Biol Psychiatry. 2000 Feb 15;47(4):314-24.

PMID:
10686266
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk